Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Lourdes M. Perez-Chada"'
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/6e08d4b630e94c81b4e3fcf451d7aa75
Autor:
Margo J. Reeder, Joseph F. Merola, Kristina Callis Duffin, Robert A. Swerlick, Vanina Taliercio, Alice B. Gottlieb, Marta J. Van Beek, Lourdes M. Perez-Chada
Publikováno v:
Journal of the American Academy of Dermatology. 88:86-93
International Dermatology Outcome Measures and the American Academy of Dermatology recently agreed on a physician-reported global severity measure to demonstrate quality of care in inflammatory dermatoses.Because patient-reported outcome measures are
Autor:
Megan H. Noe, Marjorie Archila, John S. Barbieri, Nathaniel Goldman, Christina G. Lopez, Arash Mostaghimi, Aaron M. Scherer, Alice J. Tan, Lourdes M. Perez-Chada, Maryam M. Asgari, Joel M. Gelfand
Publikováno v:
Archives of Dermatological Research.
Publikováno v:
Journal of the American Academy of Dermatology. 85:321-329
Background Severe atopic dermatitis (AD) is increasingly treated with systemic immunomodulatory drugs, yet their safety is unclear. Objective We evaluated the comparative risk of serious bacterial and opportunistic infections among patients with seve
Autor:
Mariana Soledad Martin, María Luz Bollea Garlatti, María Guillermina Ferraresso, Lourdes M. Perez-Chada, Luis Daniel Mazzuoccolo
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 5:86-92
Introduction: Biologic drugs have revolutionized the treatment of chronic inflammatory immunologic diseases. However, their use is associated with adverse reactions, including paradoxical adverse events. Tumor necrosis factor (TNF)–associated psori
Publikováno v:
The Journal of Rheumatology. 96:36-40
Autor:
Dan E. Webster, Rebecca H. Haberman, Lourdes M. Perez-Chada, Vinod Chandran, Anthony M. Reginato, Alexis Ogdie, Evan Siegel, Jose U. Scher, Soumya M. Reddy, Jessica A. Walsh, Cheryl F. Rosen, Joseph F. Merola
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 5:68-72
The Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) was established to optimize the clinical care of patients with psoriatic disease through multidisciplinary collaboration, education, and innovative research. This
Autor:
Jeffrey M. Cohen, Alice B. Gottlieb, Deepak M.W. Balak, Lourdes M. Perez-Chada, Joseph F. Merola, Alexis Ogdie
Publikováno v:
Expert Review of Clinical Immunology. 16:267-283
Introduction: The International Dermatology Outcome Measures (IDEOM) identified ‘Psoriatic Arthritis (PsA) Symptoms’ as a core domain to be measured in psoriasis clinical trials. This domain includes the measurement of pain, patient global and ph
Autor:
Kristina Callis Duffin, Heather Kornmehl, John Latella, Joseph F. Merola, Lourdes M. Perez-Chada, Alice B. Gottlieb, Sanminder Singh, Nicole Salame, Amit Garg, April W. Armstrong
Publikováno v:
Dermatology. 237:151-157
Background/Aims: In dermatology clinical trials, assessment of patients’ treatment satisfaction is crucial but often lacking. To address this need, IDEOM’s Psoriasis Working Group seeks to evaluate, develop, and validate treatment satisfaction in
Autor:
Lourdes M. Perez-Chada, Joseph F. Merola, Amit Garg, Alexis Ogdie, John Latella, April W. Armstrong, Jeffrey M. Cohen, Philip J. Mease, Alice B. Gottlieb, Kristina Callis Duffin
Publikováno v:
Journal of the American Academy of Dermatology. 82:54-61
Background The International Dermatology Outcome Measures established a set of core domains to be measured in all psoriasis trials. This set requires that symptoms of psoriatic arthritis (PsA) be measured in all psoriasis studies. Objective To identi